<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>佰傲谷BioValley | wechat-feeds</title><link>http://MzU1NTg4OTM3Mg.favicon.privacyhide.com/favicon.ico</link><description>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 07 Mar 2021 13:21:16 +0800</pubDate><image><url>http://MzU1NTg4OTM3Mg.favicon.privacyhide.com/favicon.ico</url><title>佰傲谷BioValley | wechat-feeds</title><link>http://MzU1NTg4OTM3Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>靶点药讯50|纵览全球药物靶点动态</title><link>https://mp.weixin.qq.com/s/GFHUGo8AFMg_HmrL27b4rA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaTMJp8l3Fxeyo5YGnaJVH9E2UlbkBIkbS4YY3kpu5RoPSZ8KggRKACD72eNGW0ltyQkq2JMuEDAg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>百济神州、君实生物、葛兰素史克、贝达药业、默沙东......]]></content:encoded><pubDate>Sun, 07 Mar 2021 10:11:43 +0800</pubDate></item><item><title>加快精准医疗领域的临床转化和技术开发为使命-纽蓝科技</title><link>https://mp.weixin.qq.com/s/1wC-67OnVAbHvXdLkqrV-Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpbgzDsLtcWPbCzO2RwqfePSY6L7x2MlvIWMslMedU5HBxYLtsxB7JicErOQ1aZhMlUTTbDIUyYwwnA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>叮咚！纽蓝科技向您发起好友申请！邀您相聚TG-Bio~]]></content:encoded><pubDate>Sun, 07 Mar 2021 10:11:43 +0800</pubDate></item><item><title>500余位知名药企/临床等行业人士已加盟，TG-Bio第二届免疫治疗技术大会就等你啦！</title><link>https://mp.weixin.qq.com/s/X5MAShgy86w7rDNLd7HeNw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaTMJp8l3Fxeyo5YGnaJVH9QAPffT8ibcMyBcJZFQsfLGAhLfZuUaBecKjWUvib4icAGbFcGjEpo1xkg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>早鸟优惠即将截止！速抢。]]></content:encoded><pubDate>Sun, 07 Mar 2021 10:11:43 +0800</pubDate></item><item><title>控制临床严重副作用，装载安全开关CAR-T疗法一天之内几乎消除了毒性</title><link>https://mp.weixin.qq.com/s/MMbj23GoogUeN1SQzTcufw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYmCIM98iaM7dcWr3C7s9eUZWxeib2N2QhGO0aiaL5dr77YcC9dKt1Zz9AHibVzsjeGl04u7EOC7ILNnw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 06 Mar 2021 12:39:35 +0800</pubDate></item><item><title>Moderna将开始新冠变异毒株疫苗mRNA-1273.351的首次人体试验</title><link>https://mp.weixin.qq.com/s/gdM7wTzf8ZleXLxbHxvzDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYmCIM98iaM7dcWr3C7s9eUZNVg18HYIx0iaAick9aGtq2tWxlTMBY64MszBMqpr3tKklngtBY0m03ibw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 06 Mar 2021 12:39:35 +0800</pubDate></item><item><title>百济神州PD-1替雷利珠单抗针对二或三线非小细胞肺癌的新适应症上市申请获NMPA受理</title><link>https://mp.weixin.qq.com/s/c8rwoqnxJdwBAWsuX0kyDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYmCIM98iaM7dcWr3C7s9eUZP2iazkaRIrQgGOHoDTumLia7U7sJIvUte1QUGA0aSR0H21UUugIicrFgA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 06 Mar 2021 12:39:35 +0800</pubDate></item><item><title>500余位知名药企/临床等行业人士已加盟，TG-Bio第二届免疫治疗技术大会就等你啦！</title><link>https://mp.weixin.qq.com/s/gNvQy231flumVB5TFAdN6Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaTMJp8l3Fxeyo5YGnaJVH9QAPffT8ibcMyBcJZFQsfLGAhLfZuUaBecKjWUvib4icAGbFcGjEpo1xkg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>早鸟优惠即将截止！速抢。]]></content:encoded><pubDate>Sat, 06 Mar 2021 12:39:35 +0800</pubDate></item><item><title>安进19亿美元收购Five Prime,再鼎药业拥有其FGFR2b抗体大中华区权益</title><link>https://mp.weixin.qq.com/s/tJKJQM15Dl_VCCk8LmafpA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaTMJp8l3Fxeyo5YGnaJVH9Uf9fKOOziahUz71da3qksvQgbg3QBHYwortrtTP2ubh6R40ibmYZgDBw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 05 Mar 2021 14:08:21 +0800</pubDate></item><item><title>百奥泰2020年报：研发投入5.62亿元，亏损大幅缩窄</title><link>https://mp.weixin.qq.com/s/hFEYIPj560uWfCpUM5ZBjg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaTMJp8l3Fxeyo5YGnaJVH9hCVj73q0QjiaJXgB3lByqNuMpmGS4BziaGBNhyxHEEEjq92GEZ5CoI3w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>研发投入5.62亿元，亏损大幅缩窄，创新依然坚定。]]></content:encoded><pubDate>Fri, 05 Mar 2021 14:08:21 +0800</pubDate></item><item><title>荣昌生物 1 类新药「泰它西普」即将获批</title><link>https://mp.weixin.qq.com/s/vzGvrM5Li89G5doZEup5nQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaTMJp8l3Fxeyo5YGnaJVH9Hiaib7iaFzDFEfwmAibfkCKVMGqvoRYbjOxyvLWRW4Ev5icLSR6qjogRscQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 05 Mar 2021 14:08:21 +0800</pubDate></item><item><title>500余位知名药企/临床等行业人士已加盟，TG-Bio第二届免疫治疗技术大会就等你啦！</title><link>https://mp.weixin.qq.com/s/qIN7A12mF1Iozer8dNU1CA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaTMJp8l3Fxeyo5YGnaJVH9Gic2YHBPtZAd3hR6h6OicCE2GGDqj0HXfGEayT05LAAmfEiciaiaqmtUicfA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>早鸟优惠即将截止！速抢。]]></content:encoded><pubDate>Fri, 05 Mar 2021 14:08:21 +0800</pubDate></item><item><title>启愈生物双特异性抗体Q-1802 中国获批IND</title><link>https://mp.weixin.qq.com/s/iyufEq8Uvore4ktOK0MqvA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpZB2ia4icXiaQsvGVIygstU0nGe9xv8sKgMKqf3icAbt7v5GELNqH8JH8kuw6jW37iaYracicOMBiaNqj52g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>启愈生物靶向PD-L1及Claudin18.2的双特异性抗体获批临床。]]></content:encoded><pubDate>Thu, 04 Mar 2021 12:12:22 +0800</pubDate></item><item><title>FDA拒绝Athenex口服紫杉醇上市申请，广州香雪制药引入中国（陆港澳）权益</title><link>https://mp.weixin.qq.com/s/U4kXVVovvp4sQOLU7Tv_fw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpZB2ia4icXiaQsvGVIygstU0nGDUeI9NyWOPx2ciaGibWjoibX8PoxDTKyj598mXVBY78ib5zYWjJicnNibMXg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>又双叒叕是韩美·····]]></content:encoded><pubDate>Thu, 04 Mar 2021 12:12:22 +0800</pubDate></item><item><title>首款向FDA递交上市申请的国产PD-1---君实生物特瑞普利单抗</title><link>https://mp.weixin.qq.com/s/j18TMOMZnMBpF5hCqHCyDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpZB2ia4icXiaQsvGVIygstU0nGDUeI9NyWOPx2ciaGibWjoibX8PoxDTKyj598mXVBY78ib5zYWjJicnNibMXg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国内国际市场两手抓。]]></content:encoded><pubDate>Thu, 04 Mar 2021 12:12:22 +0800</pubDate></item><item><title>以文会友 |《2021版生物制药小编精选汇编》</title><link>https://mp.weixin.qq.com/s/KcKz_URF37fMBhjQajAiNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYJvlTDRe08hISahbjxGDoNYlUT6dYdfxscdgSNX3OJC8rr53yM0cT5icNKqa43Q8gITuiakUQMGmicQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>记录最大的意义，是可以不忘记。]]></content:encoded><pubDate>Thu, 04 Mar 2021 12:12:22 +0800</pubDate></item><item><title>今日14：00，相约宜明直播间：基因和细胞治疗产品监管政策趋势与合规性探讨</title><link>https://mp.weixin.qq.com/s/2eAlO591ENB55eXUXUJ1Jw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYXibPV6jnoh1ZxFBxbQ2Z7LwLLNN5AeiaVLWRWA0VYVqOagCRyxTgtX98ibnbibL2aBdI4nzJUdGibeYA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>分享“基因和细胞治疗产品监管政策趋势与合规性探讨”的法规解读，邀您一起剖析法规脉络，规范研发注册行为。]]></content:encoded><pubDate>Wed, 03 Mar 2021 10:07:31 +0800</pubDate></item><item><title>百济神州全球化持续推进，国产首款出海1类创新药泽布替尼加拿大获批上市</title><link>https://mp.weixin.qq.com/s/FUakyoPnJ-jh0sCUp5tZNQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYFJhO5Jk8icXbYcI9bicbb7ndYUmJYgVMsWKqicMiayUqtKgmIaAgfGgVzlEjRiauib48oI2HZnOZFYxqQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>百济的全球化又一步]]></content:encoded><pubDate>Wed, 03 Mar 2021 10:07:31 +0800</pubDate></item><item><title>药明康德收购OXGENE，积极布局细胞和基因疗法</title><link>https://mp.weixin.qq.com/s/NXxQe6g-qZNp5GhbwjY9Ag</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYFJhO5Jk8icXbYcI9bicbb7ndYUmJYgVMsWKqicMiayUqtKgmIaAgfGgVzlEjRiauib48oI2HZnOZFYxqQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>佰傲谷分享]]></content:encoded><pubDate>Wed, 03 Mar 2021 10:07:31 +0800</pubDate></item><item><title>助力生物医药企业实现药品产业化，我们一直在路上</title><link>https://mp.weixin.qq.com/s/Bk1QqTL96dqwPnYe_Xqxeg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpZTYO1U3MkFGQgcCR04xJ1bSTYNaFgRHmLGH3wYgYWBh40ibNuMqskfDtC551qayn0F0Vweygv2t9g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>驾玉生物在君实生物和Coherus战略合作中的重要推动作用]]></content:encoded><pubDate>Tue, 02 Mar 2021 17:04:54 +0800</pubDate></item><item><title>清算开始？默沙东撤回K药在美小细胞肺癌适应症</title><link>https://mp.weixin.qq.com/s/UZqbKmxe-aG5DotHPAyIRw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYXibPV6jnoh1ZxFBxbQ2Z7LJ6guc9dLGcHSx7ceIsPEkdkpvs9bC8kzl5bSM0VBczrFeduFpyhtzw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>先上车，后补票，票补不上了怎么办？]]></content:encoded><pubDate>Tue, 02 Mar 2021 17:04:54 +0800</pubDate></item></channel></rss>